Background
==========

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death in women \[[@b1-medscimonit-25-9786]\]. The most commonly used methods for breast cancer screening -- digital mammography and ultrasound \[[@b2-medscimonit-25-9786]\] -- have shown an increase from 1/3 to 1/2 in breast cancers diagnosed as nonpalpable breast lesion (NBL) \[[@b3-medscimonit-25-9786],[@b4-medscimonit-25-9786]\], which is a kind of small lesion of the mammary gland that can only be detected by imaging examinations. Most of these cases are shown as microcalcifications-only in mammography and appear negative in ultrasound \[[@b5-medscimonit-25-9786]\]. According to the current standards, BI-RADS 3--5 NBL with \>2% likelihood of malignancy requires tissue diagnosis to exclude breast cancer \[[@b6-medscimonit-25-9786]\]. Unlike the mass lesions, the NBL with BI-RADS 3--5 microcalcifications-only in mammography is neither clinically palpable nor guided by ultrasound. Thus, a highly invasive strategy called three-dimensional digital breast X-ray wire positioning technology is frequently performed to locate the microcalcifications for tissue biopsy or local resection. The disadvantage of this approach is that it causes permanent physical damage and anxiety, and because only 22--50% of these lesions are malignant, there is a high false-positive rate \[[@b7-medscimonit-25-9786],[@b8-medscimonit-25-9786]\]. The recently revised recommendations for breast cancer screening have suggested that the overtreatment detected by mammography should also be taken into consideration \[[@b9-medscimonit-25-9786],[@b10-medscimonit-25-9786]\]. Therefore, finding a new way to improve diagnostic accuracy is of great importance.

Multimodality evaluation for NBL can increase the diagnostic accuracy of breast cancer \[[@b11-medscimonit-25-9786]\]. Dynamic contrast-enhanced MRI (DCE-MRI), which is a potentially useful candidate biomarker for determining the indication of stereotactic mammotomy biopsy \[[@b12-medscimonit-25-9786],[@b13-medscimonit-25-9786]\], has been shown to supply significant diagnostic information on breast lesions showing suspicious microcalcifications on mammography \[[@b14-medscimonit-25-9786]--[@b16-medscimonit-25-9786]\]. However, since traditional multimodal diagnosis greatly relies on the radiologists' experience, identifying objective multimodal diagnostic markers would contribute to improving the accuracy of NBL identification.

Radiomics can convert medical images into high-dimensional, mineable data via high-throughput extraction of quantitative features based on the established imaging modes \[[@b17-medscimonit-25-9786]\]. Thanks to the subsequent machine-learning algorithm, it has great potential to become a promising application for predicting the prognosis of breast cancer \[[@b18-medscimonit-25-9786]\] and identifying the molecular subtyping \[[@b19-medscimonit-25-9786],[@b20-medscimonit-25-9786]\]. Preliminary investigations have used radiomics to discriminate malignant tumors from benign ones by using a single modality \[[@b7-medscimonit-25-9786],[@b21-medscimonit-25-9786]\]. We believe that fusing multimodality radiomic features could provide a more comprehensive method to quantitatively measure NBL with microcalcifications-only in mammography.

In the present study, we aimed to verify the value of multimodal radiomics in identifying malignant NBL among BI-RADS 3--5 lesions showing microcalcifications-only in mammography by employing mammography and DCE-MRI data.

Material and Methods
====================

Study population
----------------

This retrospective study was approved by the Internal Research Review and Ethics Committee of our hospital. All patient data were anonymized before the data were stored in our research dataset. We enrolled patients who underwent a three-dimensional digital breast X-ray wire positioning for local resection with BI-RADS 3--5 microcalcifications-only in mammography between October 2012 and November 2016 consecutively. All the patients underwent paired breast MRI and mammography before the treatment, and all of them had pathologic reports. In this study, mass with calcifications and irregular distortion with calcifications were excluded. Finally, 81 patients were included in the study. According to pathological results, 41 benign patients were assigned to the benign group, and 40 malignant patients were assigned to the malignant group.

Data acquisition
----------------

Mammography images were acquired using the digital mammography units (Hologic Selenia, Danbury, USA). Patients underwent imaging with craniocaudal and mediolateral oblique views.

For DCE-MRI image acquisition, all patients were scanned in the prone position using a 3.0 Tesla MRI scanner (MAGNETOM Verio A Tim System; Siemens Healthcare, Erlangen, Germany) with a dedicated 8-channel double-breast coil (Siemens Healthcare, Erlangen, Germany). Contrast agent (Gadodiamide injection, GE Healthcare, Carrigtohill, Ireland) was injected at a dose of 0.1 mmol/kg using a power injector at a flow rate of 2.5 ml/s, followed by a 20-ml saline flush. DCE-MRI sequence was performed using a T1-weighted three-dimensional axial sequence \[flip angle = 12°, TR=8 ms, TE=3.93 ms, NEX=1, thickness=0.8 mm, interval=0 mm, matrix=448×448, FOV=340 mm\] before and 5 times after intravenous contrast agent administration, and each phase lasted 38 s.

Lesion segmentation
-------------------

All images were manually segmented by expert board-certified breast radiologists using ITK-SNAP software (*[www.itksnap.org](www.itksnap.org)*). Radiologists analyzed all 81 cases separately, and they were blinded to the outcomes.

For lesions in the DCE-MRI image, we segmented the ROI on the DCE-MRI image at the third postcontrast phase, which was closest to 2 min. This was in line with BI-RADS that recommends a morphologic evaluation at the early phase within 2 min \[[@b22-medscimonit-25-9786],[@b23-medscimonit-25-9786]\]. The region in the other DCE-MRI phase image was defined as corresponding to the segmented lesion at the third postcontrast phase as a tumor periphery ([Figure 1](#f1-medscimonit-25-9786){ref-type="fig"}).

Feature extraction
------------------

We extracted 3 kinds of corporate features from 2 modalities: morphology features, histogram features, and texture features. In addition, we extracted the characteristic features according to the specific diagnostic value of each modality; from mammography modality we extracted the distribution features of single calcification and the distribution characteristics of single calcification among calcifications clusters, and from DCE-MRI modality we extracted asymmetric features \[[@b24-medscimonit-25-9786]\] and Time signal Intensity Curve (TIC) features. All features were extracted by MATLAB software V2018b (*<http://www.mathworks.com>*). Finally, 69 features of microcalcification were extracted from mammography, including the features of a single calcification and between calcifications. Single calcification features include 9 morphological features, 6 histogram features, and 16 gray-level co-occurrence matrix features. The features between calcifications include 7 distribution features and 31 features regarding heterogeneity between calcifications. We extracted 37 DCE-MRI features, including 11 morphological features, 12 histogram features, 2 texture features, 8 asymmetric features, and 4 time signal intensity curve features. All extracted features are shown in detail in the supplementary materials.

Intra-observer and inter-observer agreement
-------------------------------------------

We evaluated the intra-observer and inter-observer agreements of extracting features by Intra-class Correlation Coefficient (ICC). We first selected 30 random DCE-MRI images for ROI segmentation and feature extraction. The ROI segmentations were performed independently by 2 experienced breast radiologists.

Intra-observer ICC was calculated by comparing 2 extractions of S.G.L. (who has more than 20 years' experience in breast MRI). By comparing the extractions of Z.J. (who has more than 20 years' experience in breast MRI) and the first extraction of S.G.L., Inter-observer was calculated. When the ICC was greater than 0.75, it was considered a good agreement, and the other images segmentation was performed by Z.J.

Feature selection and Classification algorithm
----------------------------------------------

First, we used the random forest-recursive feature elimination method to select the features from each modality separately \[[@b24-medscimonit-25-9786]\]. We sorted variables according to the characteristics of the descending order of importance, and then deleted the ones with the lowest importance; these same steps were repeated until the feature set was reduced to 1. We evaluated a subset of different features and then chose the minimum out of bag error subset as the chosen features. Then, we used the random forest algorithm, which is an integrated learning algorithm used to build the multimodal classifier. It is a classifier composed of many decision trees, where the output is determined by voting, and the number of votes is classified as the classification result \[[@b25-medscimonit-25-9786]\]. We used the LOOCV method to validate and improve the generalization ability of the classifiers \[[@b26-medscimonit-25-9786]\].

Statistical analysis
--------------------

Statistical differences between the features of malignant and benign lesions were analyzed by using the independent-samples *t* test. The age differences between the 2 groups were tested using a two-sample *t* test. ROC analysis was used to evaluate classifier performance. AUC was used as an index of performance. Statistical analysis was performed using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). All tests were two-tailed. P\<0.05 was considered statistically significant.

Results
=======

Patient characteristics
-----------------------

The mean age of the malignant patients was 46.67±9.4 years (range: 28--68 years), the mean age of the benign patients was 46.51±9.6 years (range: 27--59 years), and all patients were Han Chinese females. There was no significant difference in age between the groups (p\>0.05). Also, all malignant patients were early-stage breast cancer. [Table 1](#t1-medscimonit-25-9786){ref-type="table"} shows the histological types and demographic details of these subjects.

Multimodal feature extraction
-----------------------------

In this study, 69 candidate radiomics features were reduced to 6 potential mammographic features ([Figure 2A](#f2-medscimonit-25-9786){ref-type="fig"}), and 37 candidate DCE-MRI features were reduced to 8 potential features ([Figure 2B](#f2-medscimonit-25-9786){ref-type="fig"}). Based on the extraction features from multimodal images, the accuracy was the highest when the total number of features was 14 ([Figure 2C](#f2-medscimonit-25-9786){ref-type="fig"}). The contrast texture features (3/6) in mammography and the kinetic features in DCE-MRI (4/8) were the most discriminative features in joining the 2 modalities ([Table 2](#t2-medscimonit-25-9786){ref-type="table"}). In mammography, there were significant differences between malignant lesions and benign lesions in some texture features, including the variance of the contrast of the grayscale co-occurrence matrix at 0° (*P*=0.031), grayscale co-occurrence matrix at 135° (*P*=0.003), and the variance of the energy of the grayscale co-occurrence matrix at 0° (*P*\<0.001). In distribution of the calcifications range features such as SD of the distance of the calcification spot from the center (*P*\<0.001), the maximum distance between the calcification spots in the area of the radius 0.5 cm (*P*\<0.001). In DCE-MRI, there were significant differences between morphologic features such as circumference (*P*\<0.001), area (*P*=0.002), roundness (*P*\<0.001), the slope of the fitting of the first 3 points of the time signal intensity curve (*P*\<0.001), the slope of the fitting of the first 4 points of the time signal intensity curve (*P*\<0.001), and the texture feature largest variance (*P*=0.021).

The performance of multimodal classifier
----------------------------------------

We used the random forest-recursive feature elimination method to build the multimodal classifier. Our model achieved AUC 0.903, with a sensitivity of 82.5%, a specificity of 80.48%, and a classification accuracy of 81.48%, which was better than with any single model, and which indicated good diagnostic power. The classification performance of the combined features is listed in [Table 3](#t3-medscimonit-25-9786){ref-type="table"}. The performance of the Receiver Operating Characteristics (ROC) curve is shown in [Figure 3](#f3-medscimonit-25-9786){ref-type="fig"}.

Intra-observer reproducibility and inter-observer variability analysis
----------------------------------------------------------------------

The intra-observer ICC calculated based on 2 measurements of S.G.L. ranged from 0.802 to 0.978. The inter-observer agreement between 2 breast radiologists ranged from 0.781 to 0.925. The results indicated good intra- and inter-observer feature extraction reproducibility.

Discussion
==========

Mammography and DCE-MRI are 2 modalities that strongly complement each other in the differentiation of patients with malignant and benign NBL with microcalcifications-only in mammography. Mammography has high specificity for microcalcifications but low tissue contrast, while MRI has high resolution, high sensitivity (78--98%), and low specificity (43--75%) in soft tissue \[[@b27-medscimonit-25-9786]\]. Even though joining radiomic features from mammography and DCE-MRI is not an easy task in NBL with microcalcifications-only because the signs are atypical in both modalities, some atypical localized breast adenopathies can also show similar morphology microcalcifications in the ducts, like the malignant ones in mammography. Most MRI findings are non-mass-like enhancements, and the sensitivity and specificity of DCE-MRI are, in general, much lower for the diagnosis of non-mass-like enhancement lesions compared with masses \[[@b28-medscimonit-25-9786],[@b29-medscimonit-25-9786]\]. Previous multimodality computer-aided breast cancer diagnosis based on these 2 modalities has shown the improvement of single-modality mammography (AUC 0.74±0.04), DCE-MRI (AUC 0.78±0.04) to multimodality (AUC 0.87±0.03), but they only focused on the mass \[[@b30-medscimonit-25-9786]\]. Our results were different from previous reports since our study population specifically focused on NBL patients with microcalcifications-only. This kind of disease cannot be found in other commonly used screening methods and is more difficult to diagnose and to treat. We excluded the masses with calcifications, spiculation with calcifications, and architectural distortion with microcalcifications because these 3 kinds of diseases are palpable and can be localized with ultrasound. Above all, our results demonstrated that combining radiomic information from these 2 modalities had good diagnostic power and led to higher performances in accuracy, sensitivity, specificity, and AUC than with any single modality alone.

In our study, we found that the contrast texture feature in mammography and the kinetic features in DCE-MRI were the significant differentiators of malignant lesions from benign lesions in NBL patients with microcalcifications-only. We found that in mammography, the malignant lesions had significantly less clarity and groove of the image textures than benign lesions, and their texture was irregular and unstable compared to the benign lesions. We also found the malignant calcifications had more intensively clustered distribution. These differences may correspond to the way malignant microcalcifications appear on the mammogram as either linear, branching, or granular microcalcifications, which are usually coarse and are usually distributed as multiple clusters of fine granular microcalcifications \[[@b31-medscimonit-25-9786]\]. In another modality -- DCE-MRI -- we found that the malignant lesions had significantly smaller circumference and area, with no smooth edges. This difference may correspond to the appearance of ductal carcinoma, which is amorphous, depending primarily on the presence and extent of abnormal periductal or stromal vascularity. In this type of cancer, the invasive tumor tissue is densely distributed along the duct \[[@b32-medscimonit-25-9786]\]. The malignant lesions had a higher enhancing slope rate, which may correspond to the immature blood vessels in the tumor. More enhanced heterogeneity in the malignant lesions may be correlates with the higher heterogeneity in tumors.

We used the random forest algorithm to select the features and build the classifiers. We performed encapsulated feature selection to build a classifier combination method. This approach can eliminate the uncorrelated or redundant features, thus reducing the number of features, improve the accuracy of the model, and reduce the running time \[[@b33-medscimonit-25-9786]\]. It can also enable better predictive performance and model interpretation than variable selection by Least Absolute Shrinkage and Selection Operator (LASSO) \[[@b34-medscimonit-25-9786]\]. Our radiomics data were collected from a single institution, using the same equipment and protocol, thus eliminating the effects of inconsistent data on results.

Our study suggests that an appropriate quantitative scheme can reduce the false-positive rate and adjust thresholds for image-guided breast biopsy. Our results show that adding MRI examination will improve the sensitivity, specificity, AUC, and accuracy compared with the single use of mammography in the diagnosis of NBL. In light of the current high incidence of breast cancer, this will result in considerable clinical benefits. The reported results may help improve the selection process for the patients with NBL and BI-RADS 3--5 appearing as microcalcifications-only at mammography before any highly invasive strategies are used.

Our study has several limitations. First, our study was retrospective, which means that it was subjected to potential bias. Second, we had a small data set, since breast MRI is still not the routine examination for most patients with NBL calcifications-only. Third, the clinical risk factors were not incorporated. Further large-scale studies are needed to confirm our findings and to potentially identify a cutoff value with radiomics that should be used to optimize the selection of patients who will benefit from preoperative breast MRI.

Conclusions
===========

The quantitative multimodal radiomic diagnostic model is a promising method for diagnosing NBL patients with BI-RADS 3--5 microcalcifications-only. This method has the potential to become an essential diagnostic procedure and a reliable approach for clinical strategy pre-treatment. Breast MRI imaging is potentially useful to predict the presence of occult invasion in patients with suspicious calcifications.
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![An example of ROI segmentation in the left breast of a patient. (**A**) BI-RADS 4A clustered microcalcifications in the outer quadrant. (**B**) Segmentation on mammography. (**C**) Segmentation on DCE-MRI. (**D**) Dotted lines indicated that the lesion demonstrates kinetics pattern with rapid wash-in.](medscimonit-25-9786-g001){#f1-medscimonit-25-9786}

![The accuracy curve of the number of features. (**A**) Based on mammography, there is a maximum accuracy when the feature is 6. (**B**) Based on DCE-MRI, there is a maximum accuracy when the feature is 8. (**C**) Based on the extraction features from multimodal, when the total number of features was 14, the accuracy is the highest.](medscimonit-25-9786-g002){#f2-medscimonit-25-9786}

![The ROC curve of single modality and multimodality. MG -- mammography.](medscimonit-25-9786-g003){#f3-medscimonit-25-9786}

###### 

Demographic details of subjects.

  Pathology                             Statistic
  ------------------------------------- --------------------
  **Breast cancer (n=40)**              
  Age in years \[mean±SD (range)\]      46.67±9.4 (28--68)
  *Histology type*                      
                                        **Number**
  Invasive ductal carcinoma (IDC)       22
  Ductal carcinoma *in situ* (DCIS)     16
  Invasive mucinous carcinoma           1
  Invasive cribriform carcinoma         1
  **Breast benign lesions (n=41)**      
  Age in years \[mean±SD (range)\]      46.51±9.6 (27--59)
  *Histology type*                      
                                        **Number**
  Fibroadenoma                          6
  Duct ectasia                          28
  Ductal epithelial hyperplasia         30
  Cysts                                 5
  Benign proliferative breast disease   36
  Sclerosing adenosis                   1
  Intraductal papilloma                 4

###### 

Multimodal classification features and statistical significance between malignant and benign lesions.

  Characteristic                                      MG              Characteristic   DCE-MRI                                                                      
  --------------------------------------------------- --------------- ---------------- --------- -------------------------------------- ------------- ------------- ---------
  Heterogeneity between individual calcification                                                 Morphologic features                                               
  F51                                                 1.442±0.641     1,873±0.495      0.031     F70, mm^2^                             1031±738      1675±2074     0.002
  F53                                                 1.561±0.612     1.773±0.327      0.6674    F71, mm                                60.3±12.2     72.3±22.5     \<0.001
  F54                                                 1.453±0.632     1.763±0.465      0.003     F72                                    0.675±0.035   0.723±0.043   \<0.001
  F55                                                 6.18±0.28       6.61±0.26        \<0.001   Texture features                                                   
  Distribution of the calcifications range features                                              F92                                    164±28        132±39        0.021
  F65                                                 0.0284±0.0026   0.0389±0.0039    \<0.001   Time-signal intensity curve features                               
  F69                                                 0.0325±0.0027   0.0512±0.0041    \<0.001   F94                                    1.01±0.221    1.192±0.182   \<0.001
                                                                                                 F95                                    1.203±0.179   1.538±0.211   \<0.001
                                                                                                 F96                                    1.732±0.221   1.813±0.219   0.8153
                                                                                                 F97                                    2.145±0.281   2.312±0.283   0.3873

###### 

ROC curve analysis of single modality and multimodality parameters for assessment of the performance of the classifier.

  Modality              Sensitivity   Specificity   AUC     Accuracy
  --------------------- ------------- ------------- ------- ----------
  Mammography           77.50%        73.17%        0.834   75.30%
  DCE-MRI               75.00%        78.04%        0.883   76.54%
  Mammography+DCE-MRI   82.50%        80.48%        0.903   81.48%
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